Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of metformin on mRNA expression, histone modifications, and chromatin accessibility in lung cancer cells

ABSTRACT: Effect of metformin on mRNA expression, histone modifications, and chromatin accessibility in lung cancer cells

PROVIDER: PRJNA591899 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10534450_1.fastq.gz	Fastqsanger.gz
	SRR10534450_2.fastq.gz	Fastqsanger.gz
	SRR10534451_1.fastq.gz	Fastqsanger.gz
	SRR10534451_2.fastq.gz	Fastqsanger.gz
	SRR10534453_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

Effect of metformin on histone modifications in lung cancer cells

Project description:Effect of metformin on histone modifications in lung cancer cells

| PRJNA591893 | ENA

Effect of metformin on chromatin accessibility in lung cancer cells

Project description:The DNA regions whose chromatin accessibility was significantly altered by metformin were investigated in lung cancer cells by ATAC-seq. Metformin decreased chromatin accessibility in 159 regions but increased it in 124 sites. Most regions were outside of gene promoters defined as TSS ± 3kb. The most suppressed region was 4,667bp downstream of CHAC1, and the most enhanced site was 15,111bp downstream of ERRFI1.

2019-11-27 | GSE141059 | GEO

Effect of metformin on histone modifications in lung cancer cells

Project description:The DNA regions that were associated with the metformin altered expressions of H3K4me3 and/or H3K27me3 were investigated by ChIP-seq, and the regions significantly up- or down-regulated by metformin were identified in H1299 cells. Over 80% of H3K4me3 were discovered within promoter regions, but less than 10% of H3K27me3 were observed in this area. Metformin significantly downregulated H3K4me3 level at the promoter regions of 1113 genes, but upregulated levels in the promoter regions of 1492 genes. Gene enrichment analysis revealed that abundant cell cycle related genes such as PIK3C3, CCNB2, CDK1, CDK6, and E2F8 were upregulated, while certain cell cycle suppressor genes such as CDKN1A (p21) and DDIT4 were downregulated. No specific biological functional cluster was detected in the H3K27me3 up- or downregulated genes.

2019-11-27 | GSE141053 | GEO

Histone modifications in lung epithelial cells

Project description:Histone modifications in lung epithelial cells

| PRJNA594274 | ENA

Histone Modifications and Chromatin Accessibility in Endothelial Cells under Shear Stress

Project description:Histone Modifications and Chromatin Accessibility in Endothelial Cells under Shear Stress

| PRJNA527303 | ENA

Histone Modifications and Chromatin Accessibility in Endothelial Cells under Shear Stress (ATAC-seq)

Project description:This data set reveals the changes of histone modifications and chromatin accessibility in human umbilical vein endothelial cells (HUVECs) under atheroprotective pulsatile shear (PS), atheroprone oscillatory shear (OS), or with KLF4 overexpression. Using ChIP-Seq, we defined the H3K27ac and H3K4me1 enrichment under PS and OS conditions. Using ATAC-seq, we identified the chromatin accessibility under KLF4 overexpression.

2020-03-11 | GSE128390 | GEO

Histone Modifications and Chromatin Accessibility in Endothelial Cells under Shear Stress (ChIP-seq)

2020-03-11 | GSE128389 | GEO

Effect of metformin on chromatin accessibility in lung cancer cells

Project description:Effect of metformin on chromatin accessibility in lung cancer cells

| PRJNA591909 | ENA

Histone Modifications and Chromatin Accessibility in Endothelial Cells under Shear Stress (ChIP-seq)

Project description:Histone Modifications and Chromatin Accessibility in Endothelial Cells under Shear Stress (ChIP-seq)

| PRJNA527305 | ENA

Histone Modifications and Chromatin Accessibility in Endothelial Cells under Shear Stress (ATAC-seq)

Project description:Histone Modifications and Chromatin Accessibility in Endothelial Cells under Shear Stress (ATAC-seq)

| PRJNA527304 | ENA